Temporal trends in cardiogenic shock complicating acute myocardial infarction

New England Journal of Medicine

Volumn 340, Issue 15, 1999, Pages 1162-1168

  Goldberg, Robert J ^a   Samad, Navid A ^b   Yarzebski, Jorge ^b   Gurwitz, Jerry ^b   Bigelow, Carol ^b   Gore, Joel M ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; FEMALE; HOSPITAL MORTALITY; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MASSACHUSETTS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RISK FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE;

EID: 0033560676     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199904153401504     Document Type: Article

References (38)

1. Califf RM, Bengston JR. Cardiogenic shock. N Engl J Med 1994;330: 1724-30.
2. Domanski MJ, Topol EJ. Cardiogenic shock: current understandings and future research directions. Am J Cardiol 1994;74:724-6.
3. Killip T. Cardiogenic shock complicating myocardial infarction. J Am Coll Cardiol 1989;14:47-8.
4. Scheidt S, Ascheim R, Killip T III. Shock after acute myocardial infarction: a clinical and hemodynamic profile. Am J Cardiol 1970;26:556-64.
5. Gheorghiade M, Anderson J, Rosman H, et al. Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction. Am Heart J 1988;116:1212-7.
6. Kuhn LA. The treatment of cardiogenic shock. I. The nature of cardiogenic shock. Am Heart J 1967;74:578-81.
7. Kobayashi M, Niitani H, Hasegawa M, Goto H, Kuwahara K. Effect of medical treatment of acute myocardial infarction in coronary care unit -study on its effect mainly on the cases with complication. Jpn Circ J 1984; 48:650-8.
8. Goldberg R, Szklo M, Tonascia JA, Kennedy HL. Time trends in prognosis of patients with myocardial infarction: a population-based study. Johns Hopkins Med J 1979;144:73-80.
9. Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors: the MILIS Study Group. J Am Coll Cardiol 1989;14:40-6.
10. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med 1993;94:265-73.
11. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-22.
12. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995;91:873-81.
13. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O'Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988;78: 1345-51.
14. Hibbard MD, Holmes DR Jr, Bailey KR, Reeder GS, Bresnahan JF, Gersh BJ. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992;19:639-46.
15. Lee L, Erbel R, Brown TM, Laufer N, Meyer J, O'Neill WW. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol 1991;17:599-603.
16. Cheitlin MD. The aggressive war on acute myocardial infarction: is the blitzkrieg strategy changing? JAMA 1988;260:2894-6.
17. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J 1988;115:761-7.
18. Goldberg RJ, Gorak EJ, Yarzebski J, et al. A communitywide perspective of gender differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-53.
19. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981): the Worcester Heart Attack Study. JAMA 1986;255:2774-9.
20. Pagley PR, Yarzebski J, Goldberg RJ, et al. Gender differences in the treatment of patients with acute myocardial infarction: a multi-hospital, community-based perspective. Arch Intern Med 1993;153:625-9.
21. Chiriboga DE, Yarzebski J, Goldberg RJ, et al. A community-wide perspective of gender differences and temporal trends in the use of diagnostic and revascularization procedures for acute myocardial infarction. Am J Cardiol 1993;71:268-73.
22. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995;26:668-74.
23. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Recent trends in hospital mortality of acute myocardial infarction - the Worcester Heart Attack Study: have improvements been realized for all age groups? Arch Intern Med 1994;154:2202-8.
24. Goldberg RJ. Declining out-of-hospital sudden coronary death rates: additional pieces of the epidemiologic puzzle. Circulation 1989;79:1369-73.
25. Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997;126:561-82.
26. Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock: report of a co-operative clinical trial. N Engl J Med 1973;288:979-84.
27. DeWood MA, Notske RN, Hensley GR, et al. Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 1980;61:1105-12.
28. Gacioch GM, Ellis SG, Lee L, et al. Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol 1992;19:647-53.
29. O'Neill WW. Angioplasty therapy of cardiogenic shock: are randomized trials necessary? J Am Coll Cardiol 1992;19:915-7
30. Bolooki H. Emergency cardiac procedures in patients in cardiogenic shock due to complications of coronary artery disease. Circulation 1989; 79:Suppl I:I-137-I-148.
31. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the intervention era. J Am Coll Cardiol 1992;20:1482-9.
32. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
33. Van de Werf F, Arnold AER. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ 1988;297:1374-9.
34. Holmes DR Jr, Califf RM, Van de Werf F, et al. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet 1997;349:75-8.
35. Berger PB, Holmes DR Jr, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial: an observational study. Circulation 1997;96:122-7.
36. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1.
37. Col NF, Gurwitz JH, Alpert JS, Goldberg RJ. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. Am J Cardiol 1994;73:149-57.
38. Moscucci M, Bates ER. Cardiogenic shock. Cardiol Clin 1995;13:391-406.